7 Stocks Under $10 to Trade for Big Profits

As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Stocks that are in favor and making large moves is a segment of the market that I tweet about on a regular basis.These are also the exact type of stocks that I love to trade and alert in real-time.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Sangamo Biosciences

  • Thursday's Range: $5.40-$5.90
  • 52-Week Range: $4.63-$13.57
  • Thursday's Volume: 1.23 million
  • Three-Month Average Volume: 922,952

Sangamo Biosciences  (SGMO) , a clinical stage biopharmaceutical company, focused on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation. This stock closed up 3% to $5.82 in Thursday's trading session.

From a technical perspective, Sangamo Biosciences spiked notably higher on Thursday right above some previous support at $5.18 a share with above-average volume. This high-volume spike to the upside is now starting to push shares of Sangamo Biosciences within range of triggering a near-term breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term resistance at $6 a share to its 50-day moving average of $6.15 a share with high volume.

Traders should now look for long-biased trades in Sangamo Biosciences long as it's trending above Thursday's intraday low of $5.40 a share or above more key support at $5.18 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 922,952 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 20-day moving average of $6.62 a share to its 200-day moving average of $7.06 a share.

ReWalk Robotics

  • Thursday's Range: $9.44-$9.91
  • 52-Week Range: $5.55-$17.40
  • Thursday's Volume: 85,000
  • Three-Month Average Volume: 106,405

ReWalk Robotics  (RWLK) , a medical device company, designs, develops and commercializes exoskeletons for wheelchair-bound individuals. This stock traded up 4.4% to $9.80 in Thursday's trading session.

From a technical perspective, ReWalk Robotics ripped higher on Thursday right off its 200-day moving average of $9.39 a share and back above its 20-day moving average of $9.61 a share with lighter-than-average volume. This stock recently formed a double bottom chart pattern, after shares found some buying interest at $9 to $9.06 a share over the last month. Following that potential bottom, this stock has now started to trend higher, and it's quickly moving within range of triggering a big breakout trade. That trade will trigger if this stock manages to clear some near-term overhead resistance levels at $10 to $10.23 a share and then above more resistance at $10.50 to $10.79 a share with high volume.

Traders should now look for long-biased trades in ReWalk Robotics s as long as it's trending above its 50-day moving average of $9.28 a share or above those recent double bottom support levels and then once it sustains a move or close above those breakout levels with volume that hits near or above 106,405 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $11.45 to $12, or even $12.20 to $13 a share.

Accuride

  • Thursday's Range: $1.55-$1.62
  • 52-Week Range: $0.74-$4.67
  • Thursday's Volume: 569,000
  • Three-Month Average Volume: 229,026

Accuride  (ACW) , together with its subsidiaries, designs, manufactures and distributes commercial vehicle components in North America. This stock traded up 1.2% to $1.60 in Thursday's trading session.

From a technical perspective, Accuride trended modestly higher on Thursday right off its 20-day moving average of $1.55 a share and off its 50-day moving average of $1.56 a share with monster upside volume. This trend to the upside is now starting to push shares of Accuride within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $1.62 to $1.68 a share and then above more key resistance at $1.72 to $1.80 a share with high volume.

Traders should now look for long-biased trades in Accuride as long as it's trending above some near-term at $1.50 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 229,026 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $2.20 to its 200-day moving average of $2.23 a share.

BioLineRx

  • Thursday's Range: $0.92-$0.95
  • 52-Week Range: $0.85-$2.80
  • Thursday's Volume: 59,000
  • Three-Month Average Volume: 469,265

BioLineRx  (BLRX) , a clinical stage biopharmaceutical development company, engages in identifying, in-licensing and developing therapeutic candidates that address unmet medical needs. This stock traded up 3% to 95 cents per share in Thursday's trading session.

From a technical perspective, BioLineRx bounced notably higher on Thursday right off some near-term support at 93 cents per share with very light volume. This stock has been consolidating and trending sideways over the last month and change, with shares moving between 92 cents per share on the downside and $1.04 a share on the upside. Shares of BioLineRx are now starting to spike off the lower-end of its recent range, and it's beginning to move close to triggering a near-term breakout trade above the upper-end of its sideways chart pattern. That trade will trigger if this stock manages to take out some near-term resistance levels at its 20-day moving average of 98 cents per share to $1 a share and then above its 50-day moving average of $1.03 a share to $1.04 a share with high volume.

Traders should now look for long-biased trades in BioLineRx as long as it's trending above its recent low of 92 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 469,265 shares. If that breakout takes hold soon, then this stock will set up to re-test or possibly take out its next major overhead resistances levels at $1.20 to $1.26, or even its 200-day moving average of $1.29 to $1.32 a share.

Rennova Health

Rennova Health  (RNVA)  provides diagnostics and supportive software solutions to health care providers in the U.S. This stock traded up 18% to 75 cents per share in Thursday's trading session.

  • Thursday's Range: $0.62-$0.79
  • 52-Week Range: $0.52-$9.30
  • Thursday's Volume: 302,000
  • Three-Month Average Volume: 42,815

From a technical perspective, Rennova Health exploded sharply higher on Thursday right off its 20-day moving average of 64 cents per share and back above its 50-day moving average of 69 cents per share with monster upside volume flows. This strong move to the upside also briefly pushed shares of Rennova Health into breakout territory, after it cleared or flirted with some near-term overhead resistance levels at 69 to 75 cents per share. Market players should now look for a continuation move to the upside in the short-term if this stock manages to clear Thursday's intraday high of 79 cents per share with strong upside volume flows.

Traders should now look for long-biased trades in Rennova Health as long as it's trending above its 50-day moving average of 69 cents per share and then once it sustains a move or close above Thursday's intraday high of 79 cents per share with volume that hits near or above 42,815 shares. If that move gets underway soon, then this stock will set up to re-test or possibly take out is next major overhead resistance levels at 90 to 95 cents per share, or even $1 to $1.14 a share.

TransEnterix

  • Thursday's Range: $1.54-$1.78
  • 52-Week Range: $1.28-$6.10
  • Thursday's Volume: 2.22 million
  • Three-Month Average Volume: 3.02 million

TransEnterix  (TRXC) , a medical device company, focuses on the development and commercialization of surgical robotic systems. This stock traded up 12.1% to $1.75 in Thursday's trading session.

From a technical perspective, TransEnterix ripped sharply higher on Thursday right above some near-term support levels at $1.50 to $1.47 a share with decent upside volume flows. This stock recently gapped-down sharply lower from around $5 a share to its new 52-week low of $1.28 a share with monster downside volume. This move has now pushed shares of TransEnterix into extreme oversold territory, since its relative strength index reading is below 30. Oversold can always get more oversold, but this stock has now started to show some signs of strength, and it's quickly moving within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $1.80 to $2 a share with high volume.

Traders should now look for long-biased trades in TransEnterix as long as it's trending above some near-term support at $1.47 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 3.02 million shares. If that breakout materializes soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $2.15 to just above $2.50 a share. Any high-volume move above $2.50 will then give this stock a chance to re-fill some of its previous gap-down-day zone that started near $5 a share.

Electromed

  • Thursday's Range: $4.63-$4.84
  • 52-Week Range: $1.55-$5.20
  • Thursday's Volume: 72,000
  • Three-Month Average Volume: 329,763

Electromed  (ELMD)  designs, develops, manufactures, markets and sells airway clearance therapy products in the U.S. and internationally. This stock traded up 3.8% to $4.83 in Thursday's trading session.

From a technical perspective, Electromed jumped sharply higher on Thursday right off its 20-day moving average of $4.68 a share with lighter-than-average volume. This stock has been uptrending over the last month and change, with shares moving higher off its low of $3.53 a share to its recent high of $4.99 a share. During that uptrend, shares of Electromed have been making mostly higher lows and higher highs, which is bullish technical price action. This spike to the upside on Thursday is now quickly pushing this stock within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $4.93 to $5 a share and then above more key resistance levels at $5.13 to its 52-week high of $5.20 a share with high volume.

Traders should now look for long-biased trades in Electromed as long as it's trending above its 50-day moving average of $4.46 a share or above more near-term support at $4.34 a share and then once it sustains a move or close above those breakout levels with volume that registers near or above 329,763 shares. If that breakout fires off soon, then this stock will set up to enter new 52-week-high territory above $5.20, which is bullish technical price action. Some possible upside targets off that move are $6 to $6.50, or even $7 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.

More from Opinion

How to Avoid Investing in a John Schnatter: Dumbest Thing on Wall Street

How to Avoid Investing in a John Schnatter: Dumbest Thing on Wall Street

Microsoft Pops on Strong Earnings and Guidance: 8 Key Takeaways

Microsoft Pops on Strong Earnings and Guidance: 8 Key Takeaways

Microsoft's Earnings Provide Fresh Proof That the LinkedIn Deal Is Paying Off

Microsoft's Earnings Provide Fresh Proof That the LinkedIn Deal Is Paying Off

Bitcoin Prices Are Back Up, but Traditional Investors Remain Skeptical

Bitcoin Prices Are Back Up, but Traditional Investors Remain Skeptical

EBay's Soft Guidance Doesn't Reflect Well on its Attempts to Fight Off Amazon

EBay's Soft Guidance Doesn't Reflect Well on its Attempts to Fight Off Amazon